Treatment with an autophagy-inducing peptide, Tat-BECN1, overcomes the tumor growth and inhibitory effect on autophagy of deregulated receptor tyrosine kinases, such as HER2/ERBB2. The gene discussed is BECN1; the disease is neoplasm.